Takeda Philippines and the Tzu Chi Foundation forged a partnership to enhance its Patient Assistance Program, enabling patients with lymphoma and IBD to access essential treatments granting improved health outcomes, and allowing them to pursue a better quality of life.
Biopharmaceutical leader Takeda Healthcare Philippines Inc. recently inked a partnership with Tzu Chi Foundation to bolster a Patient Assistance Program (PAP) specifically benefiting patients suffering from Hodgkin Lymphoma and Inflammatory Bowel Disease (IBD).
The Tzu Chi Foundation is an international humanitarian organization that has been operating in the Philippines for 27 years. It holds special consultative status with the United Nations Economic and Social Council (UN ECOSOC) and focuses on disaster relief and rehabilitation, education, healthcare, and environmental protection, positively impacting communities in need.
